In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
201 News Items found
An illustration of a samurai and a crab.
In the Lab
Ro Versus Musashi: How One Molecule Can Turn Cancer Cells Back to Normal

Researchers identify a compound that appears to eliminate tumor cells in a dish and in mice.
Memorial Sloan Kettering scientist smiling in lab with female assistant.
The History and Future of Cancer Vaccines at MSK

Learn about MSK’s leadership in developing vaccines that teach the immune system to fight cancer.
Memorial Sloan Kettering computational biologist Ed Reznik.
In the Lab
Hiding in Plain Sight: Mitochondrial DNA May Hold Overlooked Cancer Clues

DNA in the mitochondria of cancer cells may yield insights that lead to more accurate prognoses and new treatment strategies.
whole fresh turmeric root beside a bowl of turmeric powder
The Truth About Turmeric and Cancer

Can turmeric fight cancer? Learn more from an MSK expert about what the science says.
Graphic showing 11 cancer drugs approved by the FDA based on significant work done at MSK
MSK Research Led to FDA Approvals for Cancer Drugs in 2024

The U.S. Food and Drug Administration (FDA) approved 11 cancer drugs in 2024 based on significant contributions from MSK researchers.
Jianjiong Gao, Hongxin Zhang, Nikolaus Schultz, Debyani Chakravarty, and Sarah Suehnholz stand together on a terrace
Feature
A Milestone for Precision Oncology: FDA Gives Green Light to MSK’s Genetic Database

OncoKB, a database developed and maintained by investigators at MSK, helps match patients with targeted therapies based on the mutations found in their tumors.
Dr. Urvi Shah is seen smiling at the camera.
MSK Research Reveals Connection Between Diet and Cancer

Learn more about how a clinical trial at MSK revealed important connections between the foods we eat and our cancer risk.
Pictured: ESK1 Monoclonal Antibody
In the Lab
New Molecule Targets Proteins Inside Cancer Cells

Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.
woman against grey background with her head in her hands
Feature
Coping with Shame Related to Cancer

Find out how to handle feelings of self-blame and shame that may accompany a cancer diagnosis.
A women sitting in a chair holding a bell
Top Cancer Treatment Advances at MSK in 2025

Learn about some of the most important advances in cancer treatment at MSK in 2025.